Select a Region North America

Insights

Insights From Our Experts

Articles

Case Study: Leveraging Machine Learning Models in Patient Identification and Behavior Prediction for Rare Disease Indications

When a mid-sized pharmaceutical company was challenged with trial and adoption of their immune thrombocytopenia (ITP) drug due to fierce competition and the lingering impact of COVID-19, they turned to the team of data and analytics…

Flipping the Script to Disrupt, Redefine and Accelerate the Patient Care Journey

During the COVID-19 pandemic, patients and providers began to recognize the considerable benefits of telehealth services. Patient demand and notable increases in access to care for many have compelled the industry to adopt telehealth as a…

Three Keys to Value for Unlocking the Promise of Cell Therapies

The cell therapy market continues to grow. Estimated at $101 billion in 2021, the global cell therapy market is projected to reach $247 billion by 2028, a CAGR of 13.64%.1  The revenue generation is being driven…

Macroeconomic Factors Impact Cash Flow for Pharma

Worldwide inflation, ongoing effects of the COVID-19 pandemic and other macroeconomic factors continue to negatively impact established brands at a time when pharma companies need their positive cash flow the most to continue funding R&D. Leading…

How to Ensure Speed and Efficiency When Launching in Canada

Today is an extraordinary time for medical innovation. The pharmaceutical industry is yielding protection against diseases, focusing more on rare and complex disease treatments, and the world is getting better health outcomes. Global life expectancy is…

Reimagining the Patient Care Ecosystem​

Improving Access, Removing Barriers and Speeding Up Time to Therapy Patient demand for telehealth and a flood of industry challenges are disrupting the traditional healthcare landscape. Lack of patient awareness, access to care and overburdened clinicians…

Customer Centric Approach to Medical Affairs Leveraging Digital Technology

As technology advances the needs of healthcare professionals (HCPs) and patients evolve. The onset of the COVID-19 pandemic accelerated digital adoption among these groups. Medical Affairs departments now require a digital strategy in addition to medical…

EVERSANA’s Continued Commitment to Rare Disease

World Orphan Drug Congress USA 2022 As a continued commitment to the rare disease space, EVERSANA was a proud sponsor and participant of this year’s World Orphan Drug Congress USA (WODC). Leaders including Maria Kirsch, General…

Commercialization Strategies in Oncology — The Right Partner Can Reduce Risk and Boost Rewards

Whether you are an emerging company launching your first product or an established company expanding your portfolio, a number of parallel initiatives must be developed and executed to help your therapy get out of the shadow…

In the Emerging World of Prescription Digital Therapeutics (PDTs), Can You Really be Prescriptive?

Breaking Down the 5Cs of Clinical and Commercial Success The past 2+ years of my 12-year career as a client strategy and services lead has thrown me into the ever-evolving world of prescription digital therapeutics (PDTs).…